How Often Do You Use Wegovy, and What Does the Schedule Actually Look Like?

Wegovy (semaglutide) is injected once weekly — always seven days apart, on the same day each week where possible.
The dose starts at 0.25 mg and is titrated upward roughly every four weeks by your prescriber, with 2.4 mg as the standard maintenance dose.
A higher 7.2 mg dose was MHRA-approved in 2026; your prescriber decides whether it is appropriate for you at any stage of treatment.
Swapping your injection day is allowed occasionally (as long as your two doses are at least four days apart) but timing changes should be discussed with your clinical team.

Wegovy is taken once a week, every week, on a day you choose at the start of treatment. That weekly rhythm stays constant throughout — what changes over the first few months is the dose, which your prescriber increases gradually to help your body settle in. Because Wegovy is a prescription-only medicine, the full schedule is agreed with a clinician after a proper assessment, not self-selected from a label. Our Wegovy overview covers what to expect from treatment more broadly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The weekly schedule in full: what actually happens from your first dose to maintenance

Picture your first few months on Wegovy

You've just had your consultation approved, your pen has arrived, and you're staring at it wondering whether you've picked the right day. Most people choose a day that fits naturally into their week, a Saturday morning when there's no rush, or a Sunday evening before the working week begins. That day becomes your anchor point.

The first dose, 0.25 mg, is a tolerability step. Its job is to let your digestive system adjust to semaglutide rather than deliver full therapeutic effect, so if weight loss feels slow at first, that is exactly as intended. After roughly four weeks your prescriber moves you to 0.5 mg, then 1.0 mg, 1.7 mg, and finally 2.4 mg, each step spaced around a month apart. The whole escalation takes approximately sixteen to twenty weeks. This guide on taking Wegovy explains what each stage tends to feel like.

One misconception worth setting aside gently: some people assume they need to inject more often as the dose increases, perhaps reasoning that a higher amount means more frequent injections. In fact the opposite is true; frequency stays fixed at once weekly throughout. It is only the concentration in each pen that rises, never the number of injections per week.

The NHS medicines guide for semaglutide outlines the full titration pathway and what to do if you miss a dose.

What 'once a week' means in practice when life gets in the way

A week has seven days, but plans shift. You can move your injection day occasionally, the rule is that the two doses surrounding any day-change must be at least four days apart. So if your usual day is Monday and you want to shift to Thursday for a particular week, that is workable. If the gap would be shorter than four days, wait until the following week and take it on the original day instead.

If you forget an injection entirely, the guidance is to take it as soon as you remember, provided your next scheduled dose is still at least four days away. If it is closer than that, skip the missed dose and carry on from your usual day. Never take two doses to compensate. These rules apply equally whether you are on the standard 2.4 mg maintenance dose or working toward it. More detail on timing flexibility is available if your schedule is unpredictable.

The pen itself is a pre-filled, single-use device. You inject into the abdomen, thigh, or upper arm, rotating the site each week. Storage is in the fridge at 2–8 °C; refer to your patient information leaflet for the specific window during which the pen can be kept at room temperature if you are travelling. The leaflet carries the authoritative detail, not any number you might find in an article.

The 7.2 mg dose and what it changes about frequency

In April 2026 the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, following earlier authorisation of the 7.2 mg maintenance dose itself in January of that year. If your prescriber moves you to this higher dose at any point, the injection frequency remains exactly the same: once weekly. The pen format changes; the rhythm does not.

The 7.2 mg option is licensed for adults with a BMI of 30 or above, the cardiovascular indication sits under different criteria. Clinical trials at this dose reported around 20.7% average weight reduction over 72 weeks, approaching the results seen with tirzepatide at its highest dose. Our semaglutide frequency page compares how different forms of the medicine are dosed side by side.

Whether 7.2 mg is right for you depends on how you respond to lower doses, your tolerability profile, and your prescriber's clinical judgement, not on a self-assessment. This is why the prescriber reviews your case before every dose increase, rather than simply dispatching the next pen.

Side effects that peak with frequency changes (and when to get help

Gastrointestinal side effects) nausea, loose stools, indigestion, constipation, occasional vomiting, are most noticeable in the days immediately after starting or moving to a higher dose. For most people they settle within one to two weeks as the body adjusts to the new level. They tend not to persist at the same intensity between doses once you have been on a given strength for a few weeks.

If stomach discomfort is a worry, our page on Wegovy and stomach pain goes through what is typical, what is not, and when to seek advice. The more serious signal to know about: severe, persistent abdominal pain that radiates toward the back (with or without vomiting) warrants urgent medical assessment rather than waiting for your next weekly dose. The MHRA highlighted acute pancreatitis as a known but infrequent risk associated with GLP-1 medicines in a Drug Safety Update published in January 2026.

Any suspected side effect can be reported through the Yellow Card scheme. Doing so helps the MHRA build a more complete picture of how these medicines behave in real-world use, which benefits everyone taking them.

If you are considering starting Wegovy and want to understand how the cost fits into your budget, this cost context page explains what private treatment typically includes and why the listed price is rarely the whole story. When you are ready to talk to a prescriber, start your free consultation with our clinical team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions